Table 2.
Association of demographic/clinical characteristics and receipt/tolerance of chemotherapy of patients diagnosed with SCLC aging 75 years and older who had an oncologist-consult.
| Consult with an oncologist | Began chemotherapy | Dose reduction | Incomplete chemotherapy cycles | |
|---|---|---|---|---|
| N (%)1 | N (%)2 | N (%)3 | N (%)3 | |
| Total | 171 (100) | 117 (68) | 40 (34) | 56 (48) |
|
| ||||
| Sex | P = 0.53 | P = 0.34 | P = 0.20 | |
| Male | 97 (57) | 66 (68) | 25 (38) | 35 (53) |
| Female | 74 (43) | 51 (69) | 15 (29) | 21 (41) |
|
| ||||
| Age at diagnosis | P = 0.15 | P = 0.09 | P = 0.76 | |
| 75–79 | 111 (65) | 82 (74) | 24 (29) | 40 (49) |
| ≥80 | 60 (35) | 35 (58) | 16 (46) | 16 (46) |
|
| ||||
| Year of diagnosis | P = 0.19 | P = 0.90 | P = 0.08 | |
| 2004 | 32 (19) | 17 (53) | 6 (35) | 3 (18) |
| 2005 | 35 (20) | 28 (80) | 8 (29) | 17 (61) |
| 2006 | 36 (21) | 24 (67) | 9 (38) | 13 (54) |
| 2007 | 36 (21) | 23 (64) | 7 (30) | 11 (48) |
| 2008 | 32 (19) | 25 (78) | 10 (40) | 12 (48) |
|
| ||||
| Stage | P = 0.02 | P = 0.78 | P = 0.13 | |
| Extensive | 131 (77) | 83 (63) | 28 (33) | 43 (52) |
| Limited | 38 (22) | 33 (87) | 12 (36) | 12 (36) |
| Unknown | 2 (1) | 1 (50) | 0 (0) | 1 (100) |
|
| ||||
| ECOG | P = 0.23 | P = 0.18 | P = 0.0074 | |
| 0, 1 and 2 | 70 (40) | 59 (84) | 24 (41) | 22 (37) |
| 3 and 4 | 71 (42) | 40 (56) | 11 (28) | 26 (65) |
| Missing | 30 (18) | 18 (60) | 5 (28) | 8 (44) |
|
| ||||
| Number of co-morbidities |
P = 0.844 | P = 0.514 | P = 0.894 | |
| 0 | 16 (9) | 13 (81) | 5 (38) | 7 (54) |
| 1 | 64 (38) | 41 (64) | 16 (39) | 18 (44) |
| 2 | 50 (29) | 30 (60) | 8 (27) | 16 (53) |
| ≥3 | 41 (24) | 33 (80) | 11 (33) | 15 (45) |
1Column percentage.
2Row percentage: denominator is the number who had a consult in corresponding row.
3Row percentage: denominator is the number who began chemotherapy in corresponding row.
4 P values based on Cochran-Armitage test for trend.